BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9453725)

  • 1. [Cell division: practical approach].
    Vignaud JM; Duprez A
    Ann Pathol; 1997; 17 Suppl 5():58-61. PubMed ID: 9453725
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer.
    Ishiwata N; Jinn Y; Tsukada Y; Inase N; Ichioka M; Yoshizawa Y
    Anticancer Res; 2000; 20(3A):1445-50. PubMed ID: 10928055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and expression of proliferative proteins in the developing spinal cord and spinal ganglia.
    Pospísilová E; Cernochová D; Kylarová D; Lichnovský V
    Sb Lek; 2001; 102(2):145-8. PubMed ID: 12092096
    [No Abstract]   [Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
    Meer S; Galpin JS; Altini M; Coleman H; Ali H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers.
    Czyzewska J; Guzińska-Ustymowicz K; Lebelt A; Zalewski B; Kemona A
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():64-6. PubMed ID: 15638377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
    Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
    Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
    Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies concerning the neuronal cell cycle of the cat using PCNA, Ki-67 and p53 markers.
    Gruber A; Schmidt P; Url A
    J Vet Med A Physiol Pathol Clin Med; 2004 Dec; 51(9-10):416-9. PubMed ID: 15610484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased immunohistochemical labeling indices as indicators of malignant transformation of a gastric hyperplastic polyp.
    Ajiki T; Nakamura T; Suehiro I; Mizuno H; Fujii M; Kuroda Y
    Am J Gastroenterol; 2002 Jan; 97(1):211-2. PubMed ID: 11808958
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
    Wang LD; Zhou Q; Yang CS
    J Cell Biochem Suppl; 1997; 28-29():159-65. PubMed ID: 9589362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of new tools to the characterization of Barrett mucosa].
    Fléjou JF; Chatelain D
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B20-9. PubMed ID: 10897770
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A look at the biology of spindle cell squamous carcinoma of the oral cavity: report of a case.
    Rizzardi C; Frezzini C; Maglione M; Tirelli G; Melato M
    J Oral Maxillofac Surg; 2003 Feb; 61(2):264-8. PubMed ID: 12619009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma].
    Liu J; Wang S; Chen X; Li Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):62-4. PubMed ID: 11955366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.